Conifer Holdings, Inc. (NASDAQ:CNFR – Get Free Report) was the recipient of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 5,100 shares, a drop of 61.1% from the December 15th total of 13,100 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily volume of 16,300 shares, the short-interest ratio is presently 0.3 days.
Insiders Place Their Bets
In other news, CEO Brian J. Roney sold 100,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $2.00, for a total value of $200,000.00. Following the completion of the transaction, the chief executive officer now directly owns 410,232 shares of the company’s stock, valued at approximately $820,464. This represents a 19.60 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 70.40% of the company’s stock.
Conifer Stock Performance
Shares of NASDAQ:CNFR opened at $0.98 on Thursday. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.66 and a quick ratio of 0.66. The business’s fifty day moving average price is $1.13 and its two-hundred day moving average price is $1.04. Conifer has a fifty-two week low of $0.65 and a fifty-two week high of $1.91. The stock has a market capitalization of $11.98 million, a price-to-earnings ratio of 0.41 and a beta of 0.56.
Conifer Company Profile
Conifer Holdings, Inc, an insurance holding company, engages in the sale of property and casualty insurance products. The company offers insurance coverage in specialty commercial and personal product lines. It also underwrites various specialty insurance products, including property, general liability, liquor liability, automobile, and homeowners and dwelling policies.
Featured Stories
- Five stocks we like better than Conifer
- What is MarketRankā¢? How to Use it
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- With Risk Tolerance, One Size Does Not Fit All
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- D-Wave’s Stock Springs Back in the Quantum Computing Race
Receive News & Ratings for Conifer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conifer and related companies with MarketBeat.com's FREE daily email newsletter.